2 Cheap Biotech Buyout Candidates (The Market Cap)

These 2 Biotech Takeover Targets Could Soar

Ensure you continue to get this valuable content by whitelisting us (find out how here).

Monday, August 3, 2015 Edit Subscriber Profile  |  Unsubscribe  |  Privacy Policy

Guess What We Found Inside The New Penny There have been widespread reports of a problem with the new 2015 U.S. penny. According to The Washington Post, the government has lost $100 million trying to "fix" our currency - specifically pennies and nickels. And the mint's problem with these new coins could be yet another warning sign, signaling America's next financial collapse. What's wrong with the new penny? Dr. Ron Paul explains...

FEATURE

2 Cheap Biotech Buyout Candidates Flush with cash and fresh off a stellar earnings report, this biotech company is firing on all cylinders. Bret Jensen thinks that this company, with a war chest of over $14 billion, is on the prowl for an acquisition, and he profiles two possible takeover targets that will sell for significant premiums. Get the names. Click to read more

EDITOR'S PICKS Just Revealed: Donald Trump's Personal Stock Portfolio [Tech Alert] Buy "the greatest thing" Steve Jobs said he'd ever seen [ad] OUR TOP INVESTING IDEAS   Sell This Dangerous REIT You May Own Within a sub-sector of all REITs lies a seemingly attractive group of equities that offers high dividend yields around 10%, but the real story about the safety of those dividends is much different. They are highly leveraged and any change in interest rates will be catastrophic to your investments. Click to read more Big Pharma's Big Strategy to Avoid Slowing Growth It's no secret that many analysts believe big pharma and biotech stocks are in a bubble. However, some companies are using this high-risk strategy to generate new growth opportunities while staving off a slowdown. Click to read more

© Copyright 1998-2015, Investors Alley Corp. All rights reserved. See Privacy Policy and Terms of Use | Contact Us